Analyst consensus rating
Catalyst Pharmaceuticals Analyst Consensus Rating
CPRX analyst consensus rating, coverage count and price target evidence.
Direct answer
Catalyst Pharmaceuticals's consensus rating is none.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $31.67.
Forecast evidence checked August 15, 2026.
Get free Catalyst Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $31.49
- Average price target
- $31.67
- High price target
- $32.00
- Low price target
- $31.50
- Target upside
- +0.6%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- August 15, 2026
- Valid through
- August 22, 2026